Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of iloperidone compared to
placebo and an active comparator in the treatment of patients with schizophrenia in acute
exacerbation.